Q3 2015 Holdings
Filed 2015-11-13 | 77 holdings | $325.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Catalent Inc(CTLTEUR) | COMMON | 148806102 | $473 | 19,449 | 0.0% |
| Cambrex Corp(CBM) | COMMON | 132011107 | $610 | 15,368 | 0.0% |
| China Biologic Prod | COMMON | 16938C106 | $614 | 6,840 | 0.0% |
| Pacira Pharmaceuticals(PCRX) | COMMON | 695127100 | $754 | 18,357 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COMMON | 640268108 | $1.1K | 104,399 | 0.0% |
| Horizon Pharma | SHARES | G4617B105 | $1.3K | 67,852 | 0.0% |
| Depomed Inc | COMMON | 249908104 | $1.4K | 71,994 | 0.0% |
| Lannett Co Inc | COMMON | 516012101 | $1.4K | 33,793 | 0.0% |
| Jazz Pharma PLC(JAZZ) | COMMON | G50871105 | $1.6K | 12,406 | 0.0% |
| Mckesson Corp(MCK) | COMMON | 58155Q103 | $1.7K | 9,224 | 0.0% |
| Endo Intl PLC | SHARES | G30401106 | $1.7K | 24,636 | 0.0% |
| Alkermes PLC(ALKS) | SHARES | G01767105 | $1.8K | 30,011 | 0.0% |
| Oncomed Pharmaceuticals | COMMON | 68234X102 | $1.8K | 109,211 | 0.0% |
| Impax Labs Inc | COMMON | 45256B101 | $1.8K | 52,311 | 0.0% |
| Akorn Inc(AKRXEUR) | COMMON | 009728106 | $2.0K | 68,513 | 0.0% |
| Eagle Pharmaceuticals(EGRX) | COMMON | 269796108 | $2.1K | 28,152 | 0.0% |
| Mallinckrodt PLC | SHARES | G5785G107 | $2.4K | 38,252 | 0.0% |
| Momenta Pharmaceuticals(MNTA) | COMMON | 60877T100 | $2.5K | 150,343 | 0.0% |
| ZS Pharma Inc | COMMON | 98979G105 | $2.8K | 42,000 | 0.0% |
| Valeant Pharma Intl | COMMON | 91911K102 | $3.2K | 17,839 | 0.0% |
| Perrigo Co(PRGO) | SHARES | G97822103 | $4.2K | 26,861 | 0.0% |
| Tetraphase Pharmaceuticals | COMMON | 88165N105 | $5.2K | 692,036 | 0.0% |
| Karyopharm Therapeutics(KPTIEUR) | COMMON | 48576U106 | $7.5K | 712,968 | 0.0% |
| Cigna Corp | COMMON | 125509109 | $7.5K | 55,904 | 0.0% |
| Sagent Pharmaceuticals | COMMON | 786692103 | $9.0K | 585,659 | 0.0% |
| Teladoc Inc(TDOC) | COMMON | 87918A105 | $9.3K | 417,700 | 0.0% |
| Immune Design Corp | COMMON | 45252L103 | $10.3K | 845,867 | 0.0% |
| Regenxbio Inc(RGNX) | COMMON | 75901B107 | $10.8K | 507,441 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COMMON | 46120E602 | $11.1K | 24,096 | 0.0% |
| Nxstage Medical | COMMON | 67072V103 | $11.2K | 712,329 | 0.0% |
| Heartware Intl Inc | COMMON | 422368100 | $11.7K | 224,580 | 0.0% |
| Novo-Nordisk AS(NVO) | ADR | 670100205 | $12.8K | 235,375 | 0.0% |
| Advaxis Inc | COMMON | 007624208 | $12.9K | 1,263,415 | 0.0% |
| Novartis AG(NVSN) | SP ADR | 66987V109 | $13.4K | 145,305 | 0.0% |
| Cara Therapeutics(CARAEUR) | COMMON | 140755109 | $14.6K | 1,023,309 | 0.0% |
| TG Therapeutics(TGTX) | COMMON | 88322Q108 | $14.8K | 1,464,105 | 0.0% |
| Acceleron Pharma(XLRN) | COMMON | 00434H108 | $15.2K | 612,184 | 0.0% |
| Uniqure N.V.(QURE) | SHARES | N90064101 | $15.6K | 761,913 | 0.0% |
| Relypsa Inc | COMMON | 759531106 | $15.6K | 842,030 | 0.0% |
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $16.3K | 254,901 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $16.8K | 417,082 | 0.0% |
| Pronai Therapeutics | COMMON | 74346L101 | $17.3K | 862,766 | 0.0% |
| Chimerix Inc(CMRXEUR) | COMMON | 16934W106 | $18.2K | 476,500 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMMON | 69366J200 | $18.4K | 690,364 | 0.0% |
| Aimmune Therapeutics(AIMT) | COMMON | 00900T107 | $20.1K | 792,638 | 0.0% |
| Edwards Lifescience(EW) | COMMON | 28176E108 | $21.8K | 153,115 | 0.0% |
| Unitedhealth GRP Inc(UNH) | COMMON | 91324P102 | $22.2K | 191,148 | 0.0% |
| ST Jude Medical Inc | COMMON | 790849103 | $22.4K | 354,911 | 0.0% |
| United Therapeutics(UTHR) | COMMON | 91307C102 | $23.1K | 175,780 | 0.0% |
| Alder Biopharmaceuticals(ALDR1EUR) | COMMON | 014339105 | $25.0K | 762,682 | 0.0% |